Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Phase II Trial on Extending the Maintenance Flushing Interval of Implanted Ports.

Diaz JA, Rai SN, Wu X, Chao JH, Dias AL, Kloecker GH.

J Oncol Pract. 2017 Jan;13(1):e22-e28. doi: 10.1200/JOP.2016.010843. Epub 2016 Oct 23.

PMID:
28084883
2.

A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer.

Giaccone G, Bazhenova LA, Nemunaitis J, Tan M, Juhász E, Ramlau R, van den Heuvel MM, Lal R, Kloecker GH, Eaton KD, Chu Q, Dunlop DJ, Jain M, Garon EB, Davis CS, Carrier E, Moses SC, Shawler DL, Fakhrai H.

Eur J Cancer. 2015 Nov;51(16):2321-9. doi: 10.1016/j.ejca.2015.07.035. Epub 2015 Aug 14.

PMID:
26283035
3.

Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.

Khanal S, Joh J, Kwon AM, Zahin M, Perez CA, Dunlap NE, Silverman CL, Tennant PA, Potts KL, Kloecker GH, Bumpous JM, Ghim SJ, Jenson AB, Redman RA.

Exp Mol Pathol. 2015 Oct;99(2):335-40. doi: 10.1016/j.yexmp.2015.06.018. Epub 2015 Jun 24.

PMID:
26116154
4.

Novel targeted therapies for resistant ALK-rearranged non-small-cell lung cancer: ceritinib and beyond.

Kanaan Z, Kloecker GH, Paintal A, Perez CA.

Onco Targets Ther. 2015 Apr 20;8:885-92. doi: 10.2147/OTT.S67262. eCollection 2015. Review.

5.

CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases.

Mir H, Singh R, Kloecker GH, Lillard JW Jr, Singh S.

Oncotarget. 2015 Apr 30;6(12):9985-98.

6.

CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis.

Gupta P, Sharma PK, Mir H, Singh R, Singh N, Kloecker GH, Lillard JW Jr, Singh S.

Oncotarget. 2014 Oct 30;5(20):10170-9.

7.

Expression and clinical significance of CXCR5/CXCL13 in human non‑small cell lung carcinoma.

Singh R, Gupta P, Kloecker GH, Singh S, Lillard JW Jr.

Int J Oncol. 2014 Dec;45(6):2232-40. doi: 10.3892/ijo.2014.2688. Epub 2014 Sep 30.

8.

Pooled preventable death rates in trauma patients : Meta analysis and systematic review since 1990.

Kwon AM, Garbett NC, Kloecker GH.

Eur J Trauma Emerg Surg. 2014 Jun;40(3):279-85. doi: 10.1007/s00068-013-0364-5. Epub 2014 Jan 29.

PMID:
26816061
9.

Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature.

Haninger DM, Kloecker GH, Bousamra Ii M, Nowacki MR, Slone SP.

Mod Pathol. 2014 Apr;27(4):535-42. doi: 10.1038/modpathol.2013.170. Epub 2013 Sep 13. Review.

10.

Detection of Immunoglobulin G against E7 of Human Papillomavirus in Non-Small-Cell Lung Cancer.

Storey R, Joh J, Kwon A, Jenson AB, Ghim SJ, Kloecker GH.

J Oncol. 2013;2013:240164. doi: 10.1155/2013/240164. Epub 2013 Mar 3.

11.

Radon and lung cancer.

Sethi TK, El-Ghamry MN, Kloecker GH.

Clin Adv Hematol Oncol. 2012 Mar;10(3):157-64. Review.

PMID:
22402423
12.

Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.

Agnelli G, George DJ, Kakkar AK, Fisher W, Lassen MR, Mismetti P, Mouret P, Chaudhari U, Lawson F, Turpie AG; SAVE-ONCO Investigators.

N Engl J Med. 2012 Feb 16;366(7):601-9. doi: 10.1056/NEJMoa1108898.

13.

Pemetrexed with or without matuzumab as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer.

Schiller JH, von Pawel J, Schütt P, Ansari RH, Thomas M, Saleh M, McCroskey RD, Pfeifer W, Marsland TA, Kloecker GH, Sebastian M, Pirker R, Kurek R, Beadman C, Socinski MA.

J Thorac Oncol. 2010 Dec;5(12):1977-85. doi: 10.1097/JTO.0b013e3181f4a5c9.

14.

Human papillomavirus (HPV) and Merkel cell polyomavirus (MCPyV) in non small cell lung cancer.

Joh J, Jenson AB, Moore GD, Rezazedeh A, Slone SP, Ghim SJ, Kloecker GH.

Exp Mol Pathol. 2010 Dec;89(3):222-6. doi: 10.1016/j.yexmp.2010.08.001. Epub 2010 Aug 7.

PMID:
20699096
15.

Fixed-dose every-other-week capecitabine and oxaliplatin for refractory squamous cell carcinoma of the head and neck.

Rabinowits G, Bhupalam L, Miller DM, Kloecker GH, Laber DA.

Am J Med Sci. 2010 Feb;339(2):148-51. doi: 10.1097/MAJ.0b013e3181c4bd91.

PMID:
20087165
16.

Obtaining routine blood cultures during interleukin-2-containing therapy is unnecessary.

Jaglal MV, Laber DA, Arnold FW, Miller DM, Chesney JA, Kloecker GH.

Am J Clin Oncol. 2009 Aug;32(4):429-31. doi: 10.1097/COC.0b013e31819142c7.

PMID:
19451801
17.

Exosomal microRNA: a diagnostic marker for lung cancer.

Rabinowits G, Gerçel-Taylor C, Day JM, Taylor DD, Kloecker GH.

Clin Lung Cancer. 2009 Jan;10(1):42-6. doi: 10.3816/CLC.2009.n.006.

PMID:
19289371
18.

Brain stem and clivus plasmacytoma.

Kloecker GH, Kannan CR, Laber DA, Rezazadeh A.

Am J Med Sci. 2008 Dec;336(6):503. doi: 10.1097/MAJ.0b013e31817f5ca6. No abstract available.

PMID:
19092324
19.

A phase I study of thalidomide, capecitabine and temozolomide in advanced cancer.

Laber DA, Khan MI, Kloecker GH, Schonard C, Taft BS, Salvador C.

Cancer Biol Ther. 2007 Jun;6(6):840-5. Epub 2007 Mar 5.

PMID:
17582215
20.

Lung cancer in the US and in Kentucky.

Kloecker GH, Studts JL, Laber DA, Bousamra M.

J Ky Med Assoc. 2007 Apr;105(4):159-64. Review. No abstract available.

PMID:
17494278

Supplemental Content

Loading ...
Support Center